24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent, to showcase new clinical and real-world analyses in…
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for…
Collaboration will enhance physician support, drive innovation, and improve patient outcomes NASHVILLE, Tenn. and ALBANY, N.Y. , April 30, 2025 /PRNewswire/…
Collaboration brings evidence-based recommendations into Lumeris' AI-powered platform to support physicians and improve outcomes ST. LOUIS, April 30, 2025 /PRNewswire/ -- Lumeris,…
Insight Partners leads round with participation from existing investors Afore Capital, Crossbeam Venture Partners, and Metrodora Ventures, bringing total funding…
Insight Partners leads round with participation from existing investors Afore Capital, Crossbeam Venture Partners, and Metrodora Ventures, bringing total funding…
Insight Partners leads round with participation from existing investors Afore Capital, Crossbeam Venture Partners, and Metrodora Ventures, bringing total funding…
Clearsense is amongst the first to achieve FHIR output validation, enhancing its support for real-time data exchanges, deeper analytics, and…
Clearsense is amongst the first to achieve FHIR output validation, enhancing its support for real-time data exchanges, deeper analytics, and…
Clearsense is amongst the first to achieve FHIR output validation, enhancing its support for real-time data exchanges, deeper analytics, and…